Back to Results

Biocept Inc (BIOCQ)

Biocept, Inc. is a common stock listing on OTC Markets for a biotechnology company focused on molecular oncology diagnostics. The company developed and commercialized laboratory assays intended to detect rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid in the United States. Its testing portfolio was designed to help healthcare providers identify cancer-related alterations that may support targeted therapy decisions at diagnosis, during progression, and in monitoring for resistance mechanisms. Biocept’s services covered several solid tumor indications, including breast, non-small cell lung, gastric, colorectal, prostate, pancreaticobiliary, and ovarian cancers, and it also provided CSF-based testing and research services for physicians and life sciences customers. Founded in 1997 and based in San Diego, California, Biocept filed for voluntary Chapter 7 liquidation in October 2023.

Stock Summary Fair Value Profitability & Growth Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Dividend Yield	Market Cap
OTC-BIOC.Q	Not available	Not available	Not available	0.0%	0.002 K

Smart Snapshot

Stock Overview

A fast read of the company and market metrics currently supported by the latest data.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Valuation • Fair Value

Biocept Inc (OTC-BIOC.Q) Fair Value by Valuation Model

No usable valuation estimate is currently available for Biocept Inc (OTC-BIOC.Q); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Biocept Inc (OTC-BIOC.Q). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Biocept Inc (OTC-BIOC.Q)

Review the profitability and growth indicators currently supported by the latest data.

Revenue Forecast

49.906 M

Forward revenue estimate.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Biocept Inc (OTC-BIOC.Q) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Events • Dividends

Dividend Profile for Biocept Inc (OTC-BIOC.Q)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Biocept Inc (OTC-BIOC.Q). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

Biocept Inc (OTC-BIOC.Q) Stock Forecast & Technical Outlook

Review Biocept Inc (OTC-BIOC.Q) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: daily • daily

Strong Sell

The daily technical read for Biocept Inc (OTC-BIOC.Q) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: weekly • weekly

Strong Sell

The weekly technical read for Biocept Inc (OTC-BIOC.Q) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: monthly • monthly

Strong Sell

The monthly technical read for Biocept Inc (OTC-BIOC.Q) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Biocept Inc (OTC-BIOC.Q)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy

Consolidated analyst recommendation mix

Hold

Based on the available recommendation mix, Biocept Inc (OTC-BIOC.Q) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0

Hold 1

Sell 0

FAQ • Fast Investor Answers

Biocept Inc (OTC-BIOC.Q) Stock FAQ

Data-supported answers about Biocept Inc (OTC-BIOC.Q), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value

Not available

No reliable estimate from the currently supported inputs

A reliable fair value estimate is not currently available for Biocept Inc (OTC-BIOC.Q). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The latest available data indicates no current dividend yield for Biocept Inc (OTC-BIOC.Q).

The current market capitalization listed for Biocept Inc is 0.002 K.

The ticker symbol for Biocept Inc is OTC-BIOC.Q, and the stock is listed on OTC Markets.

Biocept Inc (OTC-BIOC.Q) is listed on OTC Markets.